The Extended Gestational Age Medical Abortion Study
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This open-label, comparative study will compare the efficacy, safety, and acceptability of
200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual
misoprostol for termination of pregnancy in existing outpatient early medical abortion
services among women 57-63 days' versus 64-70 days' gestation.